The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.

Pregabalin, known to many by its trade name, “Lyrica,” works well, when, well, it works. A recent review of clinical studies involving Lyrica for the treatment of fibromyalgia concluded that only a ...

In patients with fibromyalgia, a 24-week treatment with a 50-mg/d dose of plant-derived cannabidiol did not outperform placebo in terms of pain relief or health-related quality of life. The only ...

SOLON, Ohio--(BUSINESS WIRE)--Pioneering the frontier of super-pulsed laser technology, Multi Radiance Medical highlights the impact of FibroLux Therapeutic Laser, one of the first and only ...

People who are suffering from fibromyalgia pain but don’t want to risk addiction to an opioid are closer to a new option for treatment. Tonix Pharmaceuticals TNXP reported positive Phase 3 study ...

Terpenes from the Cannabis sativa plant may be a viable medication for fibromyalgia and post-surgical pain relief, according ...

CHATHAM, NEW JERSEY / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp.

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

Many people with fibromyalgia describe the chronic condition as a "bad case of the flu that never goes away," because they have widespread pain, wake up with stiff muscles and experience brain fog, ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations ...

UCSD and the Department of Veterans Affairs Collaboration CARLSBAD, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — AVACEN Medical announced today that Dr. Francisco Cidral, ND, PhD’s ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...